Stock-Based Compensation (Tables)

9 Months Ended

Sep. 30, 2020

Stock-Based Compensation

Schedule of stock based compensation expense categories in statement of operations

The Company recorded stock‑based compensation expense in the following expense categories of its accompanying consolidated statements of operations and comprehensive loss (in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2020		2019		2020		2019
Sales and marketing	$	179	$	31	$	512	$	61
General and administrative		279		29		728		101
Research and development		85		4		246		21
Total stock‑based compensation	$	543	$	64	$	1,486	$	183

Schedule of stock option activity

				Weighted
				average
		Weighted		remaining
	Number of	average exercise		contractual term
	shares	price per share		(years)
Outstanding at January 1, 2020	1,420,942	$	10.35
Granted	160,786		14.92
Exercised	(25,763)		6.31
Canceled/forfeited	(60,575)		12.65
Outstanding at September 30, 2020	1,495,390		10.81	8.19
Vested and expected to vest at September 30, 2020	1,426,255	$	10.74	8.15
Exercisable at September 30, 2020	414,055	$	6.01	5.93

Schedule of activity relating to early exercise of stock options

	Number of
	shares
Unvested balance at January 1, 2020	755
Vested	(236)
Forfeited	(267)
Unvested balance at September 30, 2020	252

Schedule of weighted average assumptions

	Nine months ended
	September 30, 2020
Expected dividend yield	—
Expected volatility	58.6	%
Risk‑free interest rate	0.90	%
Expected term	5.96	Years